Emcure Pharmaceuticals Ltd announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...
The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology Institute (THSTI) have formally signed a...
EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise, announced the launch of Hospital Intel Suite™, one of the world’s...
OneSource Speciality Pharma has entered into a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilar medicines for global markets, reinforcing India's growing role as...
The Medtronic Engineering and Innovation Center (MEIC) in Hyderabad has initiated a series of health and development initiatives aimed at uplifting underserved local communities.
Driven by Medtronic’s core mission...
Lupin Limited announced the strategic spin-out of two promising oncology assets LNP7457 (PRMT5) and LNP8701 (SOS1) into Kaveri Therapeutics Inc. , a U.S.-based, clinical-stage oncology company dedicated to advancing targeted...